APOL1 and lipoprotein glomerulopathy: Notably, a series of 29 cases of biopsy-proven glomerular disease in patients recently vaccinated against SARS-CoV-2 identified 2 occurrences of collapsing glomerulopathy in African American/Black individuals with APOL1 HRG.6